Varivax (varicella) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
investments, rising birth rates, and growing adoption of combination vaccines. The Asia-Pacific region is poised for rapid growth, while tariffs encourage domestic production, enhancing supply resilience. Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Varivax (varicella) Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The varicella vaccine market, driven in part by the frequent chickenpox outbreaks and pediatric vaccination mandates, witnessed significant growth historically. The forecast period anticipates an expansion fueled by increased MMRV vaccine adoption, adult immunization programs, and improved healthcare investments. Key trends involve routine childhood immunization, combination vaccine adoption, and enhanced vaccine cold chain systems. The rise in public health awareness and stronger disease surveillance systems further bolsters growth prospects. Comprehensive immunization programs
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in DogsBusiness Wire
- FTC monitoring how drug companies react to patent cliff, official says 1 / 4 Dan Guarnera answers questions posed by Reuters Antitrust Correspondent Jody Godoy at Reuters Pharma USA in Philadelphia Dan Guarnera, who leads antitrust enforcement at the U.S.Acquire Media Monitor
- FTC monitoring how drug companies react to patent cliff, official says [Yahoo! Finance]Yahoo! Finance
- Imfinzi EU Approval Expands AstraZeneca Gastric Cancer Reach For Investors [Yahoo! Finance]Yahoo! Finance
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 3/12/26 - Form 3
- 2/24/26 - Form 10-K
- 2/17/26 - Form 13F-HR
- MRK's page on the SEC website